TAVR Puts the Swagger Back in Mick Jagger

Rolling Stones frontman Mick Jagger’s recent surgery is putting a huge spotlight on the transcatheter aortic valve replacement (TAVR) market. Late last week, Jagger tweeted that his procedure was a success and thanked fans for their support.   Thank you everyone for all your messages of support, I’m feeling much better now and on the mend - and also a huge thank you to all the hospital staff for doing a superb job. — Mick Jagger (@MickJagger) April 5, 2019 Problems for the 75-year-old began late last month after the rocker fell ill. As a result, the Rolling Stones had to cancel their North American tour. News eventually got out that he would be undergoing a TAVR procedure. TAVR is a minimally invasive surgery that repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Bloomberg reported that in a research note Larry Biegelsen, an analyst for Wells Fargo spoke about how Jagger’s experience was drawing attention to the space. Biegelsen wrote this will “likely raise awareness of aortic stenosis and potentially lead to more TAVR procedures which should benefit the TAVR manufacturers,” according to the report from Bloomberg . “When celebrities like Mick Jagger undergo a surgical procedure, it tends to shine a light on the underlying disease and raise awareness of the proc...
Source: MDDI - Category: Medical Devices Authors: Tags: Cardiovascular Source Type: news